Semaglutide - also known as Wegovy or Ozempic - this is a self administered injection with a pen device. Once a Week Tirzepatide - Also known as Mounjaro - This is a newer medicine than Semaglutide
It is primarily used in in vitro and in vivo biochemical research to investigate melanocortin receptor activation (MC1R, MC4R), melanin synthesis (melanogenesis), photoprotective mechanisms, and appetite regulation pathways
RETATRUTIDE (RETA) is positioned as a premium compound designed to support metabolic function, appetite control, and overall body composition goals
Side effects are usually mild but can include temporary discomfort at the injection site, redness, or slight swelling
People with genetic variants in the FTO gene (fat mass and obesity-associated gene) may experience slower initial weight loss but often show sustained results over 6+ months
You cannot look at 2.4 mg semaglutide and 15 mg tirzepatide and think the numbers are proportional